Mosaic Clinical Technologies’ AI breakthrough earns FDA “Breakthrough Device” designation
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
Germany will be the first launch market
Huwel’s diagnostic solutions leverage open RT-PCR system
Gazyva/Gazyvaro outperformed placebo across all key and secondary endpoints
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
ShunzymeX leverages a proprietary protease to streamline purification
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Subscribe To Our Newsletter & Stay Updated